Monitoring insulin-like growth factors in HIV infection and AIDS

Clinica Chimica Acta

Volumn 361, Issue 1-2, 2005, Pages 30-53

  Congote, Luis F ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Growth hormone; HAART; HIV; IGF; Lipodystrophy; Wasting

Indexed keywords

ANDROGEN; ANTIRETROVIRUS AGENT; ERYTHROPOIETIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE; TUMOR NECROSIS FACTOR ANTIBODY; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOLOGICAL MONITORING; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; GENE EXPRESSION REGULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; LIPID STORAGE; LIPODYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; WASTING SYNDROME; WEIGHT GAIN; WEIGHT REDUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANDROGENS; ERYTHROPOIETIN; HIV INFECTIONS; HUMANS; SOMATOMEDINS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 25644458577     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.05.001     Document Type: Review

References (139)

1. J. Holly Physiology of the IGF system Novartis Found Symp 262 2004 19 26
2. W.S. Cohick, and D.R. Clemmons The insulin-like growth factors Annu Rev Physiol 55 1993 131 153
3. M.M. Rechler, and D.R. Clemmons Regulatory actions of insulin-like growth factor-binding proteins Trends Endocrinol Metab 9 1998 176 183
4. V. Hwa, Y. Oh, and R.G. Rosenfeld The insulin-like growth factor-binding protein (IGFBP) superfamily Endocr Rev 20 1999 761 787
5. A.J. Butt, S.M. Firth, and R.C. Baxter The IGF axis and programmed cell death Immunol Cell Biol 77 1999 256 262
6. R. Clark The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function Endocr Rev 18 1997 157 179
7. V.H. Heemskerk, M.A. Daemen, and W.A. Buurman Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation Cytokine Growth Factor Rev 10 1999 5 14
8. K.W. Kelley From hormones to immunity: the physiology of immunology Brain Behav Immun 18 2004 95 113
9. G. Meininger, and S. Grinspoon Regulation of the growth hormone/insulin-like growth factor-I axis in HIV disease Endocrinologist 11 2001 188 195
10. R.A. Frost, C.H. Lang, and M.C. Gelato Growth hormone insulin-like growth factor axis in human immunodeficiency virus associated disease Endocrinologist 7 1997 23 31
11. J. Laurence Growth hormone in HIV/AIDS: current uses and future prospects Pediatr AIDS HIV Infect 6 1995 281 291
12. S. Hirschfeld Use of human recombinant growth hormone and human recombinant insulin-like growth factor-I in patients with human immunodeficiency virus infection Horm Res 46 1996 215 221
13. T.L. Blundell, S. Bedarkar, E. Rinderknecht, and R.E. Humbel Insulin-like growth factor: a model for tertiary structure accounting for immunoreactivity and receptor binding Proc Natl Acad Sci U S A 75 1978 180 184
14. R.C. Baxter Changes in the IGF-IGFBP axis in critical illness Best Pract Res Clin Endocrinol Metab 15 2001 421 434
15. H.P. Guler, J. Zapf, C. Schmid, and E.R. Froesch Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates Acta Endocrinol (Copenh) 121 1989 753 758
16. R.A. Frost, J. Fuhrer, R. Steigbigel, P. Mariuz, C.H. Lang, and M.C. Gelato Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system Clin Endocrinol 44 1996 501 514
17. S.I. Helle, T. Ueland, D. Ekse, S.S. Froland, J.M. Holly, and P.E. Lonning The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy J Clin Endocrinol Metab 86 2001 227 233
18. S.B. Haugaard, O. Andersen, B.R. Hansen, H. Orskov, U.B. Andersen, and S. Madsbad Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients Metab Clin Exp 53 2004 1565 1573
19. K.L. Dunn, and J.R. Davie The many roles of the transcriptional regulator CTCF Biochem Cell Biol 81 2003 161 167
20. D.H. Hamer Can HIV be Cured? Mechanisms of HIV persistence and strategies to combat it Curr HIV Res 2 2004 99 111
21. B.M. Peterlin, and D. Trono Hide, shield and strike back: how HIV-infected cells avoid immune eradication Nat Rev Immunol 3 2003 97 107
22. P.A. Volberding, A.M. Levine, D. Dieterich, D. Mildvan, R. Mitsuyasu, and M. Saag Anemia in HIV infection: clinical impact and evidence-based management strategies Clin Infect Dis 38 2004 1454 1463
23. R.S. Ferri, A. Adinolfi, A.J. Orsi, D.J. Sterken, J.C. Keruly, and S. Davis Treatment of anemia in patients with HIV infection: Part 1. The need for adequate guidelines J Assoc Nurses AIDS Care 12 2001 39 51
24. G. Zauli, and S. Capitani HIV-1-related mechanisms of suppression of CD34+ hematopoietic progenitors Pathobiology 64 1996 53 58
25. G. Zauli, M. Vitale, D. Gibellini, and S. Capitani Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor beta 1 J Exp Med 183 1996 99 108
26. M.R. DiFalco, L. Dufresne, and L.F. Congote Efficacy of an insulin-like growth factor-interleukin-3 fusion protein in reversing the hematopoietic toxicity associated with azidothymidine in mice J Pharmacol Exp Ther 284 1998 449 454
27. G. Tsarfaty, D.L. Longo, and W.J. Murphy Human insulin-like growth factor I exerts hematopoietic growth-promoting effects after in vivo administration Exp Hematol 22 1994 1273 1277
28. M. Sohmiya, and Y. Kato Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult GH deficiency Clin Endocrinol (Oxf) 55 2001 749 754
29. Centers for Disease control Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome MMWR Morb Mortal Wkly Rep 36 1983 1s 15s [Suppl.]
30. A.M. Tang, J. Forrester, D. Spiegelman, T.A. Knox, E. Tchetgen, and S.L. Gorbach Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy J Acquir Immune Defic Syndr 31 2002 230 236
31. D.A. Wheeler, C.L. Gibert, C.A. Launer, N. Muurahainen, R.A. Elion, and D.I. Abrams Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS J Acquir Immune Defic Syndr Hum Retrovirol 18 1998 80 85
32. P. Rietschel, C. Hadigan, C. Corcoran, T. Stanley, G. Neubauer, and J. Gertner Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy J Clin Endocrinol Metab 86 2001 504 510
33. S. Dolan, S. Wilkie, N. Aliabadi, M.P. Sullivan, N. Basgoz, and B. Davis Effects of testosterone administration in human immunodeficiency virus-infected women with low weight-a randomized placebo-controlled study Arch Intern Med 164 2004 897 904
34. S. Chappel Growth hormone in immune reconstitution J Acquir Immune Defic Syndr Hum Retrovirol 20 1999 423 431
35. P. Ye, D.E. Kirschner, and A.P. Kourtis The thymus during HIV disease: role in pathogenesis and in immune recovery Curr HIV Res 2 2004 177 183
36. M. Kumar, A.M. Kumar, D. Waldrop, M.H. Antoni, and C. Eisdorfer HIV-1 infection and its impact on the HPA axis, cytokines, and cognition Stress 6 2003 167 172
37. L.Y. Sun, and M.S. Evans Hsieh Jenny et al. increased neurogenesis in dentate gyrus of long-lived Ames dwarf mice Endocrinology 146 2005 1138 1144
38. M.P. Foster, E.R. Jensen, E. Montecino-Rodriguez, H. Leathers, N. Horseman, and K. Dorshkind Humoral and cell-mediated immunity in mice with genetic deficiencies of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormone Clin Immunol 96 2000 140 149
39. H.R. Nicholas, and J. Hodgkin Responses to infection and possible recognition strategies in the innate immune system of Caenorhabditis elegans Mol Immunol 41 2004 479 493
40. M.J. Munoz Longevity and heat stress regulation in Caenorhabditis elegans Mech Ageing Dev 124 2003 43 48
41. E.L. Organ, J. Sheng, H.E. Ruley, and D.H. Rubin Discovery of mammalian genes that participate in virus infection BMC Cell Biol 5 2004 41
42. R. Mukhopadhyay, W. Yu, J. Whitehead, J. Xu, M. Lezcano, and S. Pack The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide Genome Res 14 2004 1594 1602
43. J. Sheng, E.L. Organ, C. Hao, K.S. Wells, H.E. Ruley, and D.H. Rubin Mutations in the IGF-II pathway that confer resistance to lytic reovirus infection BMC Cell Biol 5 2004 32
44. A. Kartvelishvili, A. Lesner, M. Szponar, and M. Simm Microarray analysis of differentially expressed genes in cells resistant to HIV-1 Immunol Lett 93 2004 79 86
45. J. Corbeil, D. Sheeter, D. Genini, S. Rought, L. Leoni, and P. Du Temporal gene regulation during HIV-1 infection of human CD4+ T cells Genome Res 11 2001 1198 1204
46. A. Simmons, V. Aluvihare, and A. McMichael Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators Immunity 14 2001 763 777
47. C. de la Fuente, F. Santiago, L. Deng, C. Eadie, I. Zilberman, and K. Kehn Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals BMC Biochem 3 2002 14
48. Y.M. Li, S. Arkins, and R.H. McCusker Jr. Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I J Immunol 156 1996 64 72
49. S. Arkins, N. Rebeiz, and D.L. Brunke-Reese Interferon-gamma inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level Mol Endocrinol 9 1995 350 360
50. R.J. Germinario, T. DeSantis, and M.A. Wainberg Insulin-like growth factor 1 and insulin inhibit HIV type 1 replication in cultured cells AIDS Res Hum Retroviruses 11 1995 555 561
51. R.J. Germinario, S.P. Colby-Germinario, A. Acel, R. Chandok, K. Davison, and J. Mak Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression AIDS Res Hum Retroviruses 15 1999 829 836
52. U.K. Sharma, H. Song, S.J. Casella, and D.H. Schwartz Failure of insulin-like growth factor type I to suppress HIV type 1 in adult or umbilical cord mononuclear blood cells AIDS Res Hum Retroviruses 13 1997 105 110
53. T.M. Lin, L.A. Campbell, M.E. Rosenfeld, and C.C. Kuo Human monocyte-derived insulin-like growth factor-2 enhances the infection of human arterial endothelial cells by Chlamydia pneumoniae J Infect Dis 183 2001 1368 1372
54. W. Che, N. Lerner-Marmarosh, Q. Huang, M. Osawa, S. Ohta, and M. Yoshizumi Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression Circ Res 90 2002 1222 1230
55. E.J. Foulstone, K.A. Meadows, J.M. Holly, and C.E. Stewart Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis J Cell Physiol 189 2001 207 215
56. S.R. Broussard, R.H. McCusker, and J.E. Novakofski Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts Endocrinology 144 2003 2988 2996
57. C.U. Niesler, B. Urso, J.B. Prins, and K. Siddle IGF-I inhibits apoptosis induced by serum withdrawal, but potentiates TNF-alpha-induced apoptosis, in 3T3-L1 preadipocytes J Endocrinol 167 2000 165 174
58. J. Laurence, B. Grimison, and A. Gonenne Effect of recombinant human growth hormone on acute and chronic human immunodeficiency virus infection in vitro Blood 79 1992 467 472
59. P. Aukrust, F. Muller, E. Lien, I. Nordoy, N.B. Liabakk, and D. Kvale Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure J Infect Dis 179 1999 74 82
60. M.A. Wainberg, B.G. Brenner, E. Daar, J.M. Gertner, C. Olivier, and S. Kenley Lack of effect of recombinant human growth hormone on the in vitro activities of antiretroviral drugs against human immunodeficiency virus type 1 Antimicrob Agents Chemother 48 2004 2337 2340
61. J.C. Woo, G.A. Dean, A. Lavoy, R. Clark, and P.F. Moore Investigation of recombinant human insulin-like growth factor type I in thymus regeneration in the acute stage of experimental FIV infection in juvenile cats AIDS Res Hum Retroviruses 15 1999 1377 1388
62. B.Y. Nguyen, M. Clerici, D.J. Venzon, S. Bauza, W.J. Murphy, and D.L. Longo Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients AIDS 12 1998 895 904
63. A. Pires, J. Pido-Lopez, G. Moyle, B. Gazzard, F. Gotch, and N. Imami Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapy Antivir Ther 9 2004 67 75
64. M.R. Goodier, N. Imami, G. Moyle, B. Gazzard, and F. Gotch Loss of the CD56hiCD16-NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone Clin Exp Immunol 134 2003 470 476
65. L.A. Napolitano, J.C. Lo, M.B. Gotway, K. Mulligan, J.D. Barbour, and D. Schmidt Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone AIDS 16 2002 1103 1111
66. G.M. Fahy Apparent induction of partial thymic regeneration in a normal human subject: a case report J Anti Aging Med 6 2003 219 227
67. A. Vigano, M. Saresella, D. Trabattoni, V. Giacomet, B. di Natale, and M. Merlo Growth hormone in T-lymphocyte thymic and postthymic development: a study in HIV-infected children J Pediatr 145 2004 542 548
68. R. Heijligenberg, H.P. Sauerwein, G. Brabant, E. Endert, M.J. Hommes, and J.A. Romijn Circadian growth hormone secretion in asymptomatic human immune deficiency virus infection and acquired immunodeficiency syndrome J Clin Endocrinol Metab 81 1996 4028 4032
69. M. Rondanelli, D. Caselli, M. Arico, A. Maccabruni, B. Magnani, and L. Bacchella Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 response to growth hormone is impaired in HIV-infected children AIDS Res Hum Retroviruses 18 2002 331 339
70. M. Rondanelli, D. Caselli, A. Maccabruni, M. Maghnie, L. Bacchella, and A. DeStefano Involvement of hormonal circadian secretion in the growth of HIV-infected children AIDS 12 1998 1845 1850
71. P. Koutkia, B. Canavan, J. Breu, M. Torriani, J. Kissko, and S. Grinspoon Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial JAMA 292 2004 210 218
72. O. Andersen, S.B. Haugaard, A. Flyvbjerg, U.B. Andersen, H. Orskov, and S. Madsbad Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot study Eur J Clin Invest 34 2004 561 568
73. S. Grinspoon, C. Corcoran, T. Stanley, L. Katznelson, and A. Klibanski Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting J Clin Endocrinol Metab 83 1998 4251 4256
74. S. Stagi, G. Bindi, F. Galluzzi, L. Galli, R. Salti, and M. de Martino Changed bone status in human immunodeficiency virus type 1 (HIV-1) perinatally infected children is related to low serum free IGF-I Clin Endocrinol (Oxf) 61 2004 692 699
75. A.M. Van Rossum, M.I. Gaakeer, S. Verweel, N.G. Hartwig, T.F. Wolfs, and S.P. Geelen Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors Pediatr Infect Dis J 22 2003 70 76
76. D.C. Mynarcik, R.A. Frost, C.H. Lang, K. Decristofaro, M.A. Mcnurlan, and P.J. Garlick Insulin-like growth factor system in patients with HIV infection: effect of exogenous growth hormone administration J Acquir Immune Defic Syndr 22 1999 49 55
77. R.A. Frost, G.J. Nystrom, and C.H. Lang Stimulation of insulin-like growth factor finding protein-1 synthesis by interleukin-1 beta: requirement of the mitogen-activated protein kinase pathway Endocrinology 141 2000 3156 3164
78. C.A. Benbassat, D.D. Lazarus, S.B. Cichy, T.M. Evans, L.L. Moldawer, and S.F. Lowry Interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor alpha (TNF alpha) regulate insulin-like growth factor binding protein-1 (IGFBP-1) levels and mRNA abundance in vivo and in vitro Horm Metab Res 31 1999 209 215
79. J. Fan, Y.H. Li, G.J. Bagby, and C.H. Lang Modulation of inflammation-induced changes in insulin-like growth factor (IGF)-I and IGF binding protein-1 by anti-TNF antibody Shock 4 1995 21 26
80. C.H. Lang, J. Fan, R. Cooney, and T.C. Vary IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis Am J Physiol 270 1996 E430 E437
81. L.E. Underwood, J.P. Thissen, S. Lemozy, J.M. Ketelslegers, and D.R. Clemmons Hormonal and nutritional regulation of IGF-I and its binding proteins Horm Res 42 1994 145 151
82. E.A. Platz, M.N. Pollak, E.B. Rimm, N. Majeed, Y. Tao, and W.C. Willett Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men Cancer Epidemiol Biomarkers Prev 8 1999 1107 1110
83. C. Lofqvist, E. Andersson, L. Gelander, S. Rosberg, W.F. Blum, and K. Albertsson Wikland Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty J Clin Endocrinol Metab 86 2001 5870 5876
84. C. Lofqvist, E. Andersson, L. Gelander, S. Rosberg, L. Hulthen, W.F. Blum, and K. Albertsson Wikland Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio IGF-I/IGFBP-3 throughout childhood and adolescence J Clin Endocrinol Metab 90 2005 1420 1427
85. O. Panamonta, P. Kosalaraksa, B. Thinkhamrop, W. Kirdpon, C. Ingchanin, and P. Lumbiganon Endocrine function in Thai children infected with human immunodeficiency virus J Pediatr Endocrinol Metab 17 2004 33 40
86. G.J. Moyle, E.S. Daar, J.M. Gertner, D.P. Kotler, J.C. Melchior, and F. O'brien Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy J Acquir Immune Defic Syndr 35 2004 367 375
87. S. Schurgin, S. Dolan, A. Perlstein, M.P. Sullivan, N. Aliabadi, and S. Grinspoon Effects of testosterone administration on growth hormone pulse dynamics in human immunodeficiency virus-infected women J Clin Endocrinol Metab 89 2004 3290 3297
88. N. Besbas, S. Ozdemir, U. Saatci, T. Coskun, S. Ozen, and R. Topaloglu Nutritional assessment of children on haemodialysis: value of IGF-I, TNF-alpha and IL-1beta Nephrol Dial Transplant 13 1998 1484 1488
89. I. Virant-Klun, and J. Virant Fuzzy logic alternative for analysis in the biomedical sciences Comput Biomed Res 32 1999 305 321
90. P. Chomej, K. Bauer, N. Bitterlich, D.S. Hui, K.S. Chan, and H. Gosse Differential diagnosis of pleural effusions by fuzzy-logic-based analysis of cytokines Respir Med 98 2004 308 317
91. J. Schneider, G. Peltri, N. Bitterlich, M. Philipp, H.G. Velcovsky, and H. Morr Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients Clin Exp Med 2 2003 185 191
92. N.J. Pizzi Bleeding predisposition assessments in tonsillectomy/ adenoidectomy patients using fuzzy interquartile encoded neural networks Artif Intell Med 21 2001 65 90
93. K. Mulligan, C. Grunfeld, M.K. Hellerstein, R.A. Neese, and M. Schambelan Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection J Clin Endocrinol Metab 77 1993 956 962
94. A.J. Krentz, F.T. Koster, D.M. Crist, K. Finn, L.Z. Johnson, and P.J. Boyle Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex J Acquir Immune Defic Syndr 6 1993 245 251
95. S.A. Lieberman, G.E. Butterfield, D. Harrison, and A.R. Hoffman Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome J Clin Endocrinol Metab 78 1994 404 410
96. P.D. Lee, J.M. Pivarnik, J.G. Bukar, N. Muurahainen, P.S. Berry, and P.R. Skolnik A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection J Clin Endocrinol Metab 81 1996 2968 2975 [published erratum appears in]
97. M. Schambelan, K. Mulligan, C. Grunfeld, E.S. Daar, A. LaMarca, and D.P. Kotler Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial, Serostim Study Group Ann Intern Med 125 1996 873 882
98. J.G. Esposito, S.G. Thomas, L. Kingdon, and S. Ezzat Growth hormone treatment improves peripheral muscle oxygen extraction-utilization during exercise in patients with human immunodeficiency virus-associated wasting: a randomized controlled trial J Clin Endocrinol Metab 89 2004 5124 5131
99. M.A. McNurlan, P.J. Garlick, R.T. Steigbigel, K.A. DeCristofaro, R.A. Frost, and C.H. Lang Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease J Clin Invest 100 1997 2125 2132
100. N.I. Paton, P.J. Newton, D.R. Sharpstone, H.M. Ross, J. Cotton, and A.G. Calder Short-term growth hormone administration at the time of opportunistic infections in HIV-positive patients AIDS 13 1999 1195 1202
101. J.C. Lo, K. Mulligan, M.A. Noor, G.A. Lee, J.M. Schwarz, and C. Grunfeld The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study Clin Infect Dis 39 2004 732 735
102. P. Koutkia, G. Meininger, B. Canavan, J. Breu, and S. Grinspoon Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy Am J Physiol Endocrinol Metab 286 2004 E296 E303
103. P. Koutkia, B. Canavan, J. Breu, and S. Grinspoon Growth hormone responses to GHRH-arginine testing in HIV lipodystrophy J Clin Endocrinol Metab 90 2004 32 38
104. D.P. Kotler, N. Muurahainen, C. Grunfeld, C. Wanke, M. Thompson, and M. Saag Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients J Acquir Immune Defic Syndr 35 2004 239 252
105. A. Vigano, S. Mora, P. Brambilla, L. Schneider, M. Merlo, and L.D. Monti Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents AIDS 17 2003 1435 1441
106. R.A. Frost, S.A. Nachman, C.H. Lang, and M.C. Gelato Proteolysis of insulin-like growth factor-binding protein-3 in human immunodeficiency virus-positive children who fail to thrive J Clin Endocrinol Metab 81 1996 2957 2962
107. R. Johann-Liang, L. O'Neill, J. Cervia, I. Haller, Y. Giunta, and T. Licholai Energy balance, viral burden, insulin-like growth factor-1, interleukin-6 and growth impairment in children infected with human immunodeficiency virus AIDS 14 2000 683 690
108. M. de Martino, L. Galli, F. Chiarelli, A. Verrotti, M.E. Rossi, and G. Bindi Interleukin-6 release by cultured peripheral blood mononuclear cells inversely correlates with height velocity, bone age, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 serum levels in children with perinatal HIV-1 infection Clin Immunol 94 2000 212 218
109. P. Koutkia, and S. Grinspoon HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies Annu Rev Med 55 2004 303 317
110. D.L. Balog, M.E. Epstein, and M.I. Amodio-Groton HIV wasting syndrome: treatment update Ann Pharmacother 32 1998 446 458
111. D. Waters, J. Danska, K. Hardy, F. Koster, C. Qualls, and D. Nickell Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial Ann Intern Med 125 1996 865 872
112. K.J. Ellis, P.D. Lee, J.M. Pivarnik, J.G. Bukar, and N. Gesundheit Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone J Clin Endocrinol Metab 81 1996 3033 3038
113. S.R. Kupfer, L.E. Underwood, R.C. Baxter, and D.R. Clemmons Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously J Clin Invest 91 1993 391 396
114. C.S. Mantzoros, and A.C. Moses Whither recombinant human growth hormone? Ann Intern Med 125 1996 932 934
115. F.R. Steele Growth hormone and AIDS-related wasting Nat Med 2 1996 369 370
116. W.T. Cade, L.E. Fantry, S.R. Nabar, D.K. Shaw, and R.E. Keyser A comparison of Qt and a-vO2 in individuals with HIV taking and not taking HAART Med Sci Sports Exerc 35 2003 1108 1117
117. M.C. Gelato, D. Mynarcik, and M.A. Mcnurlan Soluble tumour necrosis factor alpha receptor 2, a serum marker of resistance to the anabolic actions of growth hormone in subjects with HIV disease Clin Sci 102 2002 85 90
118. S. Grinspoon, and M. Gelato Editorial: the rational use of growth hormone in HIV-infected patients J Clin Endocrinol Metab 86 2001 3478 3479
119. A. Carr, K. Samaras, and S. Burton A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 1998 F51 F58
120. J.C. Lo, K. Mulligan, M.A. Noor, J.M. Schwarz, R.A. Halvorsen, and C. Grunfeld The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation J Clin Endocrinol Metab 86 2001 3473 3480
121. D.B. Carr, K.M. Utzschneider, R.L. Hull, K. Kodama, B.M. Retzlaff, and J.D. Brunzell Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome Diabetes 53 2004 2087 2094
122. S.A. Lieberman, and A.R. Hoffman Sequelae to acromegaly-reversibility with treatment of the primary disease Horm Metab Res 22 1990 313 318
123. G. Baumann Acromegaly Endocrinol Metab Clin North Am 16 1987 685 703
124. P.J. Ratcliffe, B.L. Ebert, and J.D. Firth Oxygen regulated gene expression: erythropoietin as a model system Kidney Int 51 1997 514 526
125. K.W. Kim, S.K. Bae, O.H. Lee, M.H. Bae, M.J. Lee, and B.C. Park Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma Cancer Res 58 1998 348 351
126. J.D. Lundgren, and A. Mocroft Anemia and survival in human immunodeficiency virus Clin Infect Dis 37 Suppl. 4 2003 S297 S303
127. M.E. Geffner, D.Y. Yeh, E.M. Landaw, M.L. Scott, E.R. Stiehm, and Y.J. Bryson In vitro insulin-like growth factor-I, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected children Pediatr Res 34 1993 66 72
128. L.F. Congote, A. Brox, F.K. Lin, H.S. Lu, and A.A. Fauser The N-terminal sequence of the major erythropoietic factor of an anephric patient is identical to insulin-like growth factor I J Clin Endocrinol Metab 72 1991 727 729
129. T. Antoniou, K. Gough, D. Yoong, and G. Arbess Severe anemia secondary to a probable drug interaction between zidovudine and valproic acid Clin Infect Dis 38 2004 e38 e40
130. D. Mildvan Implications of anemia in human immunodeficiency virus, cancer, and hepatitis C virus Clin Infect Dis 37 Suppl. 4 2003 S293 S296
131. R.D. Moore Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy Semin Hematol 37 2000 18 23
132. J. Malyszko, S. Wolczynski, E. Zbroch, S. Brzosko, J. Malyszko, and M. Mysliwiec Insulin-like growth factor system components in relation to erythropoietin therapy and bone metabolism in dialyzed patients and kidney transplant recipients Nephron 90 2002 282 289
133. A. Kong, and P. Edmonds Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis Lancet Infect Dis 2 2002 692 699
134. K. Mulligan, and M. Schambelan Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting Int J Cardiol 85 2002 151 159
135. I.M. Holdaway, R.C. Rajasoorya, and G.D. Gamble Factors influencing mortality in acromegaly J Clin Endocrinol Metab 89 2004 667 674
136. B.P. Alter Growth hormone and the risk of malignancy Pediatr Blood Cancer 43 2004 534 535
137. A.G. Renehan, M. Zwahlen, C. Minder, S.T. O'Dwyer, S.M. Shalet, and M. Egger Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis Lancet 363 2004 1346 1353
138. A. Wolk The growth hormone and insulin-like growth factor I axis, and cancer Lancet 363 2004 1336 1337
139. L. Pantanowitz, T. Garcia-Caballero, and B.J. Dezube Growth hormone receptor (GH)-expressing carcinoid tumors after recombinant human GH therapy for human immunodeficiency virus-related lipodystrophy Clin Infect Dis 36 2003 370 372